Soumit Roy
Stock Analyst at Jones Trading
(1.58)
# 3,258
Out of 4,877 analysts
42
Total ratings
21.88%
Success rate
-6.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TARA Protara Therapeutics | Initiates: Buy | $21 | $3.01 | +598.84% | 1 | May 22, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $40 | $21.73 | +84.08% | 1 | May 20, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $36 → $27 | $20.38 | +32.48% | 2 | May 16, 2025 | |
| ACRV Acrivon Therapeutics | Downgrades: Hold | n/a | $1.20 | - | 2 | May 16, 2025 | |
| ONCY Oncolytics Biotech | Downgrades: Hold | n/a | $0.76 | - | 2 | May 16, 2025 | |
| MURA Mural Oncology | Downgrades: Hold | n/a | $2.48 | - | 2 | Mar 25, 2025 | |
| CRVO CervoMed | Upgrades: Buy | $15 | $6.30 | +138.28% | 3 | Mar 13, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $1.98 | +406.33% | 1 | Mar 12, 2025 | |
| BEAM Beam Therapeutics | Upgrades: Buy | $34 | $17.22 | +97.44% | 2 | Mar 10, 2025 | |
| INAB IN8bio | Upgrades: Buy | $36 | $2.08 | +1,631.27% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $2.40 | +1,233.33% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.71 | - | 1 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $7.74 | +16.28% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $10.21 | +66.50% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $2.23 | +482.96% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $4 | $0.63 | +539.69% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.82 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.80 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $7.57 | +243.46% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $23.23 | +201.33% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $35.53 | -71.85% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.11 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $7.79 | +926.61% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.97 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $4.00 | +7,900.20% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $4.21 | +19,139.90% | 1 | Feb 24, 2021 |
Protara Therapeutics
May 22, 2025
Initiates: Buy
Price Target: $21
Current: $3.01
Upside: +598.84%
ArriVent BioPharma
May 20, 2025
Initiates: Buy
Price Target: $40
Current: $21.73
Upside: +84.08%
Enliven Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $36 → $27
Current: $20.38
Upside: +32.48%
Acrivon Therapeutics
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.20
Upside: -
Oncolytics Biotech
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.76
Upside: -
Mural Oncology
Mar 25, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.48
Upside: -
CervoMed
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $6.30
Upside: +138.28%
Nuvation Bio
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $1.98
Upside: +406.33%
Beam Therapeutics
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $17.22
Upside: +97.44%
IN8bio
Feb 11, 2025
Upgrades: Buy
Price Target: $36
Current: $2.08
Upside: +1,631.27%
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $2.40
Upside: +1,233.33%
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.71
Upside: -
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $7.74
Upside: +16.28%
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $10.21
Upside: +66.50%
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $2.23
Upside: +482.96%
Sep 11, 2024
Maintains: Buy
Price Target: $6 → $4
Current: $0.63
Upside: +539.69%
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.82
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $5.80
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $7.57
Upside: +243.46%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $23.23
Upside: +201.33%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $35.53
Upside: -71.85%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.11
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $7.79
Upside: +926.61%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.97
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $4.00
Upside: +7,900.20%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $4.21
Upside: +19,139.90%